The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Understanding the late immune checkpoint inhibitor (ICI) symptom experience using an electronic patient reported outcomes (ePRO) app-based platform: The Immunowave study.
 
Anissa Chan
Employment - Gilead Sciences
 
Salene M.W. Jones
No Relationships to Disclose
 
Emily Enright
No Relationships to Disclose
 
Aleksandra Raczka
No Relationships to Disclose
 
Vivian Nguyen
No Relationships to Disclose
 
Shailender Bhatia
Stock and Other Ownership Interests - Moderna Therapeutics
Honoraria - Bristol-Myers Squibb; EMD Serono; EMD Serono; Genentech/Roche; Incyte; Sanofi/Regeneron; Sanofi/Regeneron
Consulting or Advisory Role - Bristol Myers Squibb; Bristol-Myers Squibb; EMD Serono; EMD Serono; Exicure; Genentech/Roche; Sanofi/Regeneron; Sanofi/Regeneron; Sanofi/Regeneron (Inst)
Research Funding - 4SC (Inst); Amphivena (Inst); Bristol-Myers Squibb (Inst); Checkmate Pharmaceuticals (Inst); EMD Serono (Inst); Exicure (Inst); Incyte (Inst); Merck (Inst); NantWorks (Inst); Nektar (Inst); Novartis (Inst); Seven and Eight Biopharmaceuticals (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - NantWorks; Sanofi/Regeneron
 
John A. Thompson
Consulting or Advisory Role - Alpine Immune Sciences; Bristol-Myers Squibb; Mabquest
Research Funding - Agensys (Inst); Five Prime Therapeutics (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); PMV Pharma (Inst); Trillium Therapeutics (Inst); Xencor (Inst)
 
Sylvia Lee
Research Funding - Bristol-Meyers Squibb (Inst); Iovance Biotherapeutics (Inst); Kite, a Gilead company (Inst); PACT Pharma (Inst); SeaGen (Inst); Tmunity Therapeutics, Inc. (Inst)
 
Joshua Veatch
Stock and Other Ownership Interests - Lyell Immunopharma
Research Funding - Gilead Sciences
Patents, Royalties, Other Intellectual Property - There are 3 patents on which I am an inventor that have been licensed
 
Scott S. Tykodi
Honoraria - Cancer Network; FirstWord; Targeted Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Merck
Research Funding - AVEO (Inst); Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Exelixis (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending (Inst)
 
Matt Lashey
Employment - Treatment Technologies and Insights
Leadership - Treatment Technologies and Insights
Stock and Other Ownership Interests - Treatment Technologies and Insights
Consulting or Advisory Role - Bayer Germany (Inst); Treatment Technologies and Insights (Inst)
Travel, Accommodations, Expenses - Bayer Germany (Inst)
 
Evan Thomas Hall
Research Funding - ImCheck therapeutics (Inst); Nektar (Inst); Neoleukin Therapeutics (Inst); NiKang Therapeutics (Inst); Replimune (Inst); Treatment Technologies and Insights (Inst)